Cargando…

Role of autophagy in K-RAS- and B-RAF-driven lung cancers

Detalles Bibliográficos
Autor principal:	White, Eileen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072929/ http://dx.doi.org/10.1186/2049-3002-2-S1-O11

Ejemplares similares

An engineered protein antagonist of K-Ras/B-Raf interaction
por: Kauke, Monique J., et al.
Publicado: (2017)

Role of Ras isoforms in γδ T-cell development
por: Marín-Marín, Ana V, et al.
Publicado: (2012)

Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers
por: Kinsey, Conan G., et al.
Publicado: (2019)

Activation of the ErbB3-AKT axis promotes melanoma cell survival and proliferation in response to RAF/MEK inhibition
por: Fattore, Luigi, et al.
Publicado: (2014)

Ras-driven cancer cells can scavenge exogenous lipids to support their proliferation
por: Kamphorst, Jurre J, et al.
Publicado: (2012)

Does Ras Activate Raf and PI3K Allosterically?
por: Nussinov, Ruth, et al.
Publicado: (2019)

RAF inhibitors promote RAS-RAF interaction by allosterically disrupting RAF autoinhibition
por: Jin, Ting, et al.
Publicado: (2017)

Molecular recognition of RAS/RAF complex at the membrane: Role of RAF cysteine-rich domain
por: Travers, Timothy, et al.
Publicado: (2018)

Exploiting the bad eating habits of Ras-driven cancers
por: White, Eileen
Publicado: (2013)

Receptor for activated C-kinase (RACK1) plays a central role in Ras-mediated signal transduction
por: Lillehaug, Johan R, et al.
Publicado: (2010)

Autophagy provides metabolic substrates to maintain energy charge and nucleotide pools in Ras-driven lung cancer cells
por: Guo, Jessie Yanxiang, et al.
Publicado: (2016)

OA01.48. Prativish chincha ras in the management of Dhatura poising
por: Singh, Babita
Publicado: (2012)

Effects of RAF inhibitors on PI3K/AKT signalling depend on mutational status of the RAS/RAF signalling axis
por: Fritsche-Guenther, Raphaela, et al.
Publicado: (2016)

Mechanisms of TIGIT-driven immune suppression in cancer
por: Kurtulus, Sema, et al.
Publicado: (2014)

Inhibition of the PI3K/AKT/mTOR pathway activates autophagy and compensatory Ras/Raf/MEK/ERK signalling in prostate cancer
por: Butler, Dominika E., et al.
Publicado: (2017)

The potential role of NF-kB activation and synthesis of pro-inflammatory mediators in the pathogenesis of allergic contact dermatitis induced by thiuram
por: Kowalewski, Cezary, et al.
Publicado: (2015)

5-Arylidene(chromenyl-methylene)-thiazolidinediones: Potential New Agents against Mutant Oncoproteins K-Ras, N-Ras and B-Raf in Colorectal Cancer and Melanoma
por: Nastasă, Cristina, et al.
Publicado: (2019)

The ErbB receptor tyrosine kinases and their roles in cancer
por: Hynes, NE
Publicado: (2003)

Ras and Raf pathways in epidermis development and carcinogenesis
por: Kern, F, et al.
Publicado: (2011)

Ras and Raf pathways in epidermis development and carcinogenesis
por: Kern, F, et al.
Publicado: (2011)

KRAS interaction with RAF1 RAS-binding domain and cysteine-rich domain provides insights into RAS-mediated RAF activation
por: Tran, Timothy H., et al.
Publicado: (2021)

The SUMOylation machinery is dispensable for Tax-induced NF-kB activation
por: Pène, Sabrina, et al.
Publicado: (2014)

OA19 A complex case of bilateral pneumothoraces due to probable certolizumab driven rheumatoid lung nodules
por: Ahmed, Sajeel, et al.
Publicado: (2023)

Autophagy turns specific: the discovery of p62 and NBR1 as autophagy cargo receptors
por: Bjørkøy, Geir
Publicado: (2010)

Role of protein arginine methyltransferase 5 over-expression in HTLV-1-driven cellular transformation and leukemia
por: Panfil, Amanda R, et al.
Publicado: (2014)

Ultra-Low Tidal Volumes And Extracorporeal Carbon Dioxide Removal (Hemolung(®) Ras) in Ards Patients. a Clinical Feasibility Study
por: Parrilla, FJ, et al.
Publicado: (2015)

Inter-cellular adhesion disruption and the RAS/RAF and beta-catenin signalling in lung cancer progression
por: Götz, Rudolf
Publicado: (2008)

Autophagy: the pathogenic agent in muscle damage
por: Raben, Nina
Publicado: (2013)

Loss of RAF kinase inhibitor protein is involved in myelomonocytic differentiation and aggravates RAS-driven myeloid leukemogenesis
por: Caraffini, Veronica, et al.
Publicado: (2020)

K-Ras and B-Raf oncogenes inhibit colon epithelial polarity establishment through up-regulation of c-myc
por: Magudia, Kirti, et al.
Publicado: (2012)

Crystal Structure Reveals the Full Ras–Raf Interface and Advances Mechanistic Understanding of Raf Activation
por: Cookis, Trinity, et al.
Publicado: (2021)

OA06-05. Adaptation of HIV-1 to the human immune system at the population level is driven by protective HLA-B alleles
por: Schellens, IM, et al.
Publicado: (2009)

RAF dimer inhibition enhances the antitumor activity of MEK inhibitors in K‐RAS mutant tumors
por: Yuan, Xi, et al.
Publicado: (2020)

Selective Regulation of B-Raf Dependent K-Ras/Mitogen-Activated Protein by Natural Occurring Multi-kinase Inhibitors in Cancer Cells
por: Abd El Maksoud, Ahmed I., et al.
Publicado: (2019)

Lung cancer staging
por: Diederich, Stefan, et al.
Publicado: (2015)

Polymorphisms in RAS/RAF/MEK/ERK Pathway Are Associated with Gastric Cancer
por: Gonzalez-Hormazabal, Patricio, et al.
Publicado: (2018)

Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy
por: Degirmenci, Ufuk, et al.
Publicado: (2020)

Session: Evaluation of lung nodules: role of PET/CT
por: Bellomi, Massimo, et al.
Publicado: (2014)

Inhibition of mutant RAS-RAF interaction by mimicking structural and dynamic properties of phosphorylated RAS
por: Ilter, Metehan, et al.
Publicado: (2022)

Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway
por: Carrot-Zhang, Jian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8j9ul1mo8ltm3caj9iqpb35j6r